Medications for Giant Cell Arteritis

2 results
  • actemra - tocilizumab injection, solution, concentrate

    (Tocilizumab)
    Genentech, Inc.
    Actemra (tocilizumab) treats moderately to severely active rheumatoid arthritis, giant cell arteritis, SSc-associated interstitial lung disease, polyarticular and systemic juvenile idiopathic arthritis (ages 2+), CAR T cell-induced cytokine release syndrome, and hospitalized COVID-19 patients requiring oxygen support or mechanical ventilation.
  • rinvoq - upadacitinib tablet, extended release

    (Upadacitinib)
    Abbvie Inc.
    RINVOQ is a JAK inhibitor indicated for adults and some pediatric patients with rheumatoid arthritis, psoriatic arthritis, atopic dermatitis, ulcerative colitis, Crohn's disease, ankylosing spondylitis, non-radiographic axial spondyloarthritis, polyarticular juvenile idiopathic arthritis, and giant cell arteritis, generally after inadequate response to TNF blockers.